Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference
Kindred Biosciences (NASDAQ: KIN) will present at two key healthcare conferences: the Barclays Global Healthcare Conference on March 10, 2021, and the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. Dr. Richard Chin, CEO, will be available for one-on-one meetings to discuss recent developments and study results of their therapeutic programs. Presentations will be available via webcast, with recordings accessible for 30 days afterward. Kindred Biosciences focuses on developing innovative biologics aimed at improving pet health.
- None.
- None.
SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Barclays Global Healthcare Conference on March 10 and the H.C. Wainwright Global Life Sciences Conference on March 9-10.
Dr. Richard Chin, Chief Executive Officer, will be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.
Conference Details:
Barclays Global Healthcare Conference
Date: March 10, 2021
Presentation time: 2:25 – 2.50p.m. ET, Virtual Track 3
Webcast URL: Click here
H.C. Wainwright Global Life Sciences Conference
Date: March 9-10, 2021
Presentation time: On demand access beginning March 9
Webcast URL: Click here
An archived version of the above webcasts will be available for 30 days on the KindredBio website.
About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-barclays-global-healthcare-conference-and-hc-wainwright-global-life-sciences-conference-301238002.html
SOURCE Kindred Biosciences, Inc.
FAQ
When will Kindred Biosciences present at the Barclays Global Healthcare Conference?
What is the presentation time for Kindred Biosciences at the Barclays Conference?
What is the date of the H.C. Wainwright Global Life Sciences Conference?
Who will represent Kindred Biosciences at the healthcare conferences?
Will there be archived webcasts for Kindred Biosciences presentations?
